We are live on !
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
Turnover
31.08%
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.92%
AUM
$91.7B
AUM Growth
+$307M
(+0.34%)
Cap. Flow
-$3.9B
Cap. Flow % of AUM
Cap. Flow %
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
9.09%
Holding
3,750
New
412
Increased
1,673
Reduced
1,111
Closed
524
Avg Time Held
2.2
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.42% |
| 2 | Technology | 15.02% |
| 3 | Financials | 12.22% |
| 4 | Consumer Discretionary | 9.92% |
| 5 | Real Estate | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Align Technology
ALGN
$11B
| $990M | 1.08% |
2,894,800
-63,800
| -2% | -$19M |
2013 Q2
20 quarters
|
|
2
Domino's
DPZ
$10.5B
| $974M | 1.06% |
3,451,500
-80,600
| -2% | -$20.4M |
2013 Q2
20 quarters
|
|
3
VeriSign
VRSN
$27.5B
| $950M | 1.04% |
6,915,100
-11,776
| -0.2% | -$1.51M |
2013 Q2
20 quarters
|
|
4
Novo Nordisk
NVO
$174B
| $883M | 0.96% |
38,284,600
+4,102,000
| +12% | +$97.5M |
2013 Q2
20 quarters
|
|
5
Humana
HUM
$50.6B
| $828M | 0.9% |
2,783,500
-465,600
| -14% | -$136M |
2015 Q2
12 quarters
|
|
|
VMW
6
DELISTED
VMware, Inc
VMW
| $777M | 0.85% |
5,289,800
+1,512,500
| +40% | +$209M |
2014 Q3
15 quarters
|
|
7
Palo Alto Networks
PANW
$290B
| $766M | 0.83% |
22,354,200
-4,322,400
| -16% | -$144M |
2015 Q2
12 quarters
|
|
8
PepsiCo
PEP
$189B
| $758M | 0.83% |
6,962,850
-2,115,412
| -23% | -$219M |
2013 Q2
20 quarters
|
|
|
9
Apple
AAPL
$5.08T
| $707M | 0.77% |
+15,275,332
| New | +$693M |
2018 Q2
0 quarters
|
|
10
Amgen
AMGN
$242B
| $702M | 0.77% |
3,803,600
-121,700
| -3% | -$21.5M |
2013 Q2
20 quarters
|
|
11
Vertex Pharmaceuticals
VRTX
$136B
| $688M | 0.75% |
4,050,617
+1,199,700
| +42% | +$186M |
2017 Q1
5 quarters
|
|
|
ABMD
12
DELISTED
Abiomed Inc
ABMD
| $635M | 0.69% |
1,551,423
+401,800
| +35% | +$146M |
2015 Q1
13 quarters
|
|
13
Bristol-Myers Squibb
BMY
$129B
| $584M | 0.64% |
10,547,200
-3,981,100
| -27% | -$215M |
2016 Q2
8 quarters
|
|
14
Crown Castle
CCI
$33.5B
| $570M | 0.62% |
5,289,703
-491,200
| -8% | -$51M |
2015 Q1
13 quarters
|
|
15
Intuitive Surgical
ISRG
$157B
| $562M | 0.61% |
3,523,230
-922,800
| -21% | -$141M |
2013 Q2
20 quarters
|
|
16
Cboe Global Markets
CBOE
$34.2B
| $540M | 0.59% |
5,190,200
+683,700
| +15% | +$72.2M |
2013 Q2
20 quarters
|
|
|
17
Meta Platforms (Facebook)
META
$1.65T
| $479M | 0.52% |
+2,467,488
| New | +$446M |
2018 Q2
0 quarters
|
|
18
Idexx Laboratories
IDXX
$44.6B
| $473M | 0.52% |
2,169,929
+81,025
| +4% | +$16.7M |
2013 Q2
20 quarters
|
|
19
Dell
DELL
$288B
| $469M | 0.51% |
19,774,902
+2,832,062
| +17% | +$62.6M |
2017 Q1
5 quarters
|
|
20
Colgate-Palmolive
CL
$77.6B
| $467M | 0.51% |
7,200,900
-2,022,700
| -22% | -$132M |
2013 Q2
20 quarters
|
|
|
21
Johnson & Johnson
JNJ
$644B
| $454M | 0.49% |
3,740,300
+2,455,901
| +191% | +$306M |
2015 Q3
11 quarters
|
|
22
FirstEnergy
FE
$26.9B
| $431M | 0.47% |
12,007,408
+2,251,708
| +23% | +$77.1M |
2014 Q1
17 quarters
|
|
23
Progressive
PGR
$133B
| $420M | 0.46% |
7,094,900
+1,163,500
| +20% | +$71.2M |
2015 Q4
10 quarters
|
|
24
BP
BP
$129B
| $414M | 0.45% |
9,623,315
+1,720,781
| +22% | +$72.3M |
2017 Q2
4 quarters
|
|
25
Best Buy
BBY
$20.9B
| $394M | 0.43% |
5,279,100
-264,000
| -5% | -$19.5M |
2016 Q1
9 quarters
|
|
Similar funds
Jim Simons's Q2 2018 Portfolio in Review
As of Q2 2018, Jim Simons held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Jim Simons opened a new position in Apple worth $707M.
- Jim Simons's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Jim Simons added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Jim Simons's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Jim Simons fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Jim Simons's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Jim Simons opened 412 new positions and closed 524 in Q2 2018.
- Jim Simons's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.